Orthofix International | OFIX - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 140.72M 2.71M 2026-03
Dexcom USD 936.6M 0 2026-03
EDAP TMS EUR 18.8M 3.01M 2025-09
Globus Medical USD 595.85M 49.26M 2026-03
Inogen USD 49.14M 665K 2024-09
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
J&J USD 17.44B 1.53B 2026-03
Medtronic USD 7.72B 436M 2026-03
Mesa Laboratories USD 33.98M 2.03M 2024-12
Orthofix International USD 213.79M 12.36M 2025-12
Plus Therapeutics USD 7.11M 1.23M 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
STAAR Surgical USD 76.12M 7.38M 2026-03
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
Veracyte USD 119.99M 3.99M 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03